Trump's 100% Tariffs on Pharmaceuticals Raise Concerns Over Healthcare Access

President Trump's announcement of a 100% tariff on certain foreign pharmaceuticals has raised significant concerns regarding drug prices and accessibility for millions of Americans reliant on essential medications. The policy, aimed at boosting domestic production, threatens to increase healthcare costs and complicate international trade relations, leaving many questioning its broader implications for the pharmaceutical industry and consumer access to necessary treatments.